KILITCH
Start SIP
Invest Now
Start SIP in KILITCH
Kilitch Drugs(I) live price: ₹327.75. It opened at ₹323 vs previous close ₹318; intraday high/low: ₹330/₹317. The 50 & 200 DMA stand at ₹331.45/₹353.44.
Kilitch Drugs(I) Performance
- Low
- ₹317
- High
- ₹330
- 52 Week Low
- ₹294
- 52 Week High
- ₹500
- Open Price₹323
- Previous Close₹318
- Volume7,977
- 50 DMA₹331.45
- 100 DMA₹342.73
- 200 DMA₹353.44
Investment Returns
- Over 1 Month -10.46%
- Over 3 Month -4.07%
- Over 6 Month -10.49%
- Over 1 Year + 9.45%
Smart Investing Starts Here Start SIP with Kilitch Drugs(I) for Steady Growth!
Kilitch Drugs(I) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 22
- PEG Ratio
- 0.7
- Market Cap Cr
- 573
- P/B Ratio
- 2.1
- Average True Range
- 13.57
- EPS
- 14.9
- Dividend Yield
- 0
- MACD Signal
- -4.65
- RSI
- 51.48
- MFI
- 63.53
Kilitch Drugs(I) Financials
Kilitch Drugs(I) Technicals
EMA & SMA
Current Price
₹327.75
+
9.85
(3.1%)
- Bearish Moving Average 8
- Bullish Moving Average 8
- 20 Day
- ₹323.75
- 50 Day
- ₹331.45
- 100 Day
- ₹342.73
- 200 Day
- ₹353.44
Resistance and Support
324.93
- R3 345.77
- R2 337.88
- R1 332.82
- S1 319.87
- S2 311.98
- S3 306.92
Kilitch Drugs(I) Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-11 | Quarterly Results & Bonus issue | |
| 2025-11-13 | Quarterly Results | |
| 2025-08-13 | Quarterly Results | |
| 2025-07-02 | Others | Inter-alia, to consider 1. Fund Raising by way of issue of equity shares of face value of 10/-each through Rights Issue. 2. Deployment of the proceeds of the Right Issue. 3. Other business matters. issue of equity shares of Rs. 10/- in the ratio of 2:23 @ premium of Rs. 347/-. |
| 2025-05-19 | Audited Results |
Kilitch Drugs(I) F&O
About Kilitch Drugs(I)
- NSE Symbol
- KILITCH
- BSE Symbol
- 524500
- Managing Director
- Mr. Mukund P Mehta
- ISIN
- INE729D01010
Similar Stocks to Kilitch Drugs(I)
Kilitch Drugs(I) FAQs
Kilitch Drugs(I) share price is ₹327 As on 12 March, 2026 | 23:42
The Market Cap of Kilitch Drugs(I) is ₹572.9 Cr As on 12 March, 2026 | 23:42
The P/E ratio of Kilitch Drugs(I) is 22 As on 12 March, 2026 | 23:42
The PB ratio of Kilitch Drugs(I) is 2.1 As on 12 March, 2026 | 23:42
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.